AFT.NZ

AFT Pharmaceuticals Limited

HealthcareDrug Manufacturers - Specialty & GenericNZNZDPeers →via fmp_bulkCountry macro →

$3.97

Jun 02, 2026

Market cap

—

52w range

—

P / E

—

EPS · FY 2026

$0.14

Volume

—

Revenue · FY 2026

$254.71M

Explain this page

Arphra AIPlain-English read on AFT Pharmaceuticals Limited’s valuation

○

Insider buys and sells are sourced from SEC Form 4 filings, which cover US-listed issuers. We don't have Form 4 history for this name.

Transactions

0 buys · 0 sells

Bought

Open market

Sold

Open market

Net flow

+$0

Buys − sells

Insider	Role	Action	Shares	Price	Value	Trade date	Filing
No open-market insider activity in this window.

13F position evolution

No 13F history in institutional_holders for AFT.NZ.

Pro

Detailed insider buy/sell history is included with Pro.